A Study of Belzutifan (MK-6482) in Participants With Renal Impairment (MK-6482-021)

Clinical trial NCT04994522 · COMPLETED

Trial details

NCT number: NCT04994522
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

End Stage Renal Disease Renal Impairment

Start date: 2022-07-12
Primary completion: 2024-04-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.